Regeneron pairs with BioNTech on melanoma immunotherapyRegeneron and Sanofi’s PD-1 inhibitor Libtayo will be tested in tandem with a cancer vaccine developed by BioNTech Share XRegeneron pairs with BioNTech on melanoma immunotherapyhttps://pharmaphorum.com/news/regeneron-pairs-with-biontech-on-melanoma-immunotherapy/
Regeneron gets closer to ISA Pharma with new immuno-oncology allianceRegeneron has doubled down in its ongoing collaboration with ISA Pharma, taking a bigger stake in the Dutch Share XRegeneron gets closer to ISA Pharma with new immuno-oncology alliancehttps://pharmaphorum.com/news/regeneron-gets-closer-to-isa-pharma-with-new-immuno-oncology-alliance/
